BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Treatment
86 results:

  • 1. Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
    Li Y; Gong B; Guo Y; Liu W; Chen C; Jiang S; Pan F; Song J; Yang L; Zhou G
    BMC Cancer; 2024 Apr; 24(1):535. PubMed ID: 38671373
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials.
    Wang C; Wang J; Qi Y
    J Ethnopharmacol; 2024 Jun; 327():118044. PubMed ID: 38484953
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparing the use of aggressive end-of life care among frail and non-frail patients with cancer using a claims-based frailty index.
    Sachdev R; Shearn-Nance G; Vu L; Bensken WP; Douglas SL; Koroukian SM; Rose J
    J Geriatr Oncol; 2024 Mar; 15(2):101706. PubMed ID: 38320468
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Explainable deep learning-based survival prediction for non-small cell lung cancer patients undergoing radical radiotherapy.
    Astley JR; Reilly JM; Robinson S; Wild JM; Hatton MQ; Tahir BA
    Radiother Oncol; 2024 Apr; 193():110084. PubMed ID: 38244779
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive evaluation of smoking exposures and their interactions on DNA methylation.
    Hoang TT; Lee Y; McCartney DL; Kersten ETG; Page CM; Hulls PM; Lee M; Walker RM; Breeze CE; Bennett BD; Burkholder AB; Ward J; Brantsæter AL; Caspersen IH; Motsinger-Reif AA; Richards M; White JD; Zhao S; Richmond RC; Magnus MC; ; Koppelman GH; Evans KL; Marioni RE; Håberg SE; London SJ
    EBioMedicine; 2024 Feb; 100():104956. PubMed ID: 38199042
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Radiotranscriptomics of non-small cell lung carcinoma for assessing high-level clinical outcomes using a machine learning-derived multi-modal signature.
    Trivizakis E; Koutroumpa NM; Souglakos J; Karantanas A; Zervakis M; Marias K
    Biomed Eng Online; 2023 Dec; 22(1):125. PubMed ID: 38102586
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial.
    Tewari KS; Colombo N; Monk BJ; Dubot C; Cáceres MV; Hasegawa K; Shapira-Frommer R; Salman P; Yañez E; Gümüs M; Olivera Hurtado de Mendoza M; Samouëlian V; Castonguay V; Arkhipov A; Tekin C; Li K; Toker S; Keefe SM; Lorusso D
    JAMA Oncol; 2024 Feb; 10(2):185-192. PubMed ID: 38095881
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With lung cancer.
    Wong A; Riley M; Zhao S; Zimmer J; Viveiros M; Wang JG; Esguerra V; Li M; Lopez G; Kendra K; Carbone DP; He K; Alahmadi A; Kaufman J; Memmott RM; Shields PG; Brownstein J; Haglund K; Welliver M; Otterson GA; Presley CJ; Wei L; Owen DH; Ho K
    J Natl Compr Canc Netw; 2023 Nov; 21(11):1164-1171.e5. PubMed ID: 37935100
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation.
    Emerging Risk Factors Collaboration
    Lancet Diabetes Endocrinol; 2023 Oct; 11(10):731-742. PubMed ID: 37708900
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
    Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
    BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic Prediction Value and Biological Functions of Non-Apoptotic Regulated Cell Death Genes in lung Adenocarcinoma.
    Li HL; Wang JX; Dai HW; Liu JJ; Liu ZY; Zou MY; Zhang L; Wang WR
    Chin Med Sci J; 2023 Sep; 38(3):178-190. PubMed ID: 37622313
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
    Brown SM; Barkauskas CE; Grund B; Sharma S; Phillips AN; Leither L; Peltan ID; Lanspa M; Gilstrap DL; Mourad A; Lane K; Beitler JR; Serra AL; Garcia I; Almasri E; Fayed M; Hubel K; Harris ES; Middleton EA; Barrios MAG; Mathews KS; Goel NN; Acquah S; Mosier J; Hypes C; Salvagio Campbell E; Khan A; Hough CL; Wilson JG; Levitt JE; Duggal A; Dugar S; Goodwin AJ; Terry C; Chen P; Torbati S; Iyer N; Sandkovsky US; Johnson NJ; Robinson BRH; Matthay MA; Aggarwal NR; Douglas IS; Casey JD; Hache-Marliere M; Georges Youssef J; Nkemdirim W; Leshnower B; Awan O; Pannu S; O'Mahony DS; Manian P; Awori Hayanga JW; Wortmann GW; Tomazini BM; Miller RF; Jensen JU; Murray DD; Bickell NA; Zatakia J; Burris S; Higgs ES; Natarajan V; Dewar RL; Schechner A; Kang N; Arenas-Pinto A; Hudson F; Ginde AA; Self WH; Rogers AJ; Oldmixon CF; Morin H; Sanchez A; Weintrob AC; Cavalcanti AB; Davis-Karim A; Engen N; Denning E; Taylor Thompson B; Gelijns AC; Kan V; Davey VJ; Lundgren JD; Babiker AG; Neaton JD; Lane HC;
    Lancet Respir Med; 2023 Sep; 11(9):791-803. PubMed ID: 37348524
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center.
    Ruggeri RM; Spagnolo CC; Alibrandi A; Silvestris N; Cannavò S; Santarpia M
    J Endocrinol Invest; 2023 Nov; 46(11):2399-2409. PubMed ID: 37076759
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Inequalities in survival and care across social determinants of health in a cohort of advanced lung cancer patients in Quebec (Canada): A high-resolution population-level analysis.
    Qureshi S; Boily G; Boulanger J; Pagé É; Strumpf E
    Cancer Med; 2023 Jun; 12(11):12683-12704. PubMed ID: 37017510
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Peripheral location of lung cancer is associated with higher local disease recurrence.
    Fourdrain A; Anastay V; Pauly V; Braggio C; D'Journo XB; Boulate D; Thomas PA
    Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 37010510
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Optimizing lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing lung Screening.
    Foley KL; Dressler EV; Weaver KE; Sutfin EL; Miller DP; Bellinger C; Kittel C; Stone RJ; Petty WJ; Land SR; Spangler JG; Lesser GJ; Chiles C;
    Chest; 2023 Aug; 164(2):531-543. PubMed ID: 36931460
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Myllylahti L; Ropponen J; Lax M; Lassila R; Nykänen AI
    Clin Appl Thromb Hemost; 2023; 29():10760296231158369. PubMed ID: 36890726
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial.
    Zhong WZ; Yan HH; Chen KN; Chen C; Gu CD; Wang J; Yang XN; Mao WM; Wang Q; Qiao GB; Cheng Y; Xu L; Wang CL; Chen MW; Kang XZ; Yan WP; Liao RQ; Yang JJ; Zhang XC; Liu SY; Zhou Q; Wu YL
    Signal Transduct Target Ther; 2023 Feb; 8(1):76. PubMed ID: 36823150
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Consolidative high-dose thoracic radiotherapy for limited metastatic nonsmall cell lung cancer: Focusing on oligo-progressive disease.
    Kim H; Yang DS; Kim SM
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):385-391. PubMed ID: 36464919
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non-Small Cell lung cancer.
    Yu B; Jun Ma S; Waldman O; Dunne-Jaffe C; Chatterjee U; Turecki L; Gill J; Yendamuri K; Iovoli A; Farrugia M; Singh AK
    JAMA Netw Open; 2022 Sep; 5(9):e2230704. PubMed ID: 36074462
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.